Letters
Reducing unnecessary use of proton pump inhibitors
Objective testing is useful to support PPI deprescribing
BMJ 2022; 379 doi: https://doi.org/10.1136/bmj.o2812 (Published 23 November 2022) Cite this as: BMJ 2022;379:o2812
- Ian L P Beales, consultant gastroenterologist
- Norfolk and Norwich University Hospital, Norwich, UK
- i.beales{at}uea.ac.uk
Proton pump inhibitors (PPIs) are overused. Farrell and colleagues have outlined useful ways to approach deprescribing.1
Putative gastro-oesophageal reflux disease probably accounts for a large proportion of long term PPI prescribing. The clinical diagnosis of gastro-oesophageal reflux disease is notoriously unreliable and upper gastrointestinal endoscopy yields normal results in at least 50% of patients with pathological reflux—more if …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.